Related Experiment Video
Updated: Jan 28, 2026

Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells
Published on: May 4, 2018
Inflammatory activity and vitamin D levels in an MS population treated with rituximab
Johan Linden1, Gabriel Granåsen2, Jonatan Salzer1
1Department of Pharmacology and Clinical Neuroscience, Umeå University, Sweden.
Background:
Most multiple sclerosis patients on disease-modifying treatment at Umeå University Hospital are treated with rituximab and the prevalence of vitamin D supplementation has increased over time. Follow-up studies of these off-label treatments are needed.
Objective:
To study inflammatory activity and adverse effects in rituximab-treated multiple sclerosis patients, and associations with 25-hydroxy-vitamin D levels.
Methods:
Retrospectively collected data on repeated estimates of relapses, disability, side effects, magnetic resonance imaging, laboratory measures including 25-hydroxy-vitamin D levels and self-perceived health.
Results:
In 272 multiple sclerosis patients with a mean follow-up of 43 months, we identified seven possible relapses during active rituximab treatment. On magnetic resonance imaging examination, new T2 lesions were seen in 1.3% (10 out of 792 scans), and 0.25% (two out of 785 scans) showed contrast enhancement. Adjusted 25-hydroxy-vitamin D levels in samples drawn close to all magnetic resonance images with new T2 lesions were lower compared to the remainder (62 vs. 81 nmol/l; P = 0.030). Levels of 25-hydroxy-vitamin D were associated with self-perceived health (r = 0.18, P = 0.041, n = 130) and C-reactive protein (r = -0.13, P = 0.042) but not with the risk of side effects.
Conclusion:
The inflammatory activity in this rituximab-treated multiple sclerosis population that increasingly used vitamin D supplementation was extremely low. Higher 25-hydroxy-vitamin D levels were associated with beneficial outcomes.
Insights
Rituximab treatment for multiple sclerosis showed very low inflammatory activity and few relapses. Higher vitamin D levels were linked to better self-perceived health and lower C-reactive protein in these patients.
Area of Science:
- Neurology
- Immunology
- Endocrinology
Background:
- Rituximab is a common disease-modifying treatment for multiple sclerosis (MS) at Umeå University Hospital.
- There's a growing trend of vitamin D supplementation among MS patients on rituximab.
- Follow-up studies are essential to evaluate the efficacy and safety of these off-label treatments.
Purpose of the Study:
- To assess inflammatory markers and adverse events in MS patients receiving rituximab.
- To investigate the relationship between 25-hydroxy-vitamin D levels and clinical outcomes in this cohort.
- To explore associations between vitamin D status and treatment-related side effects.
Main Methods:
- Retrospective analysis of clinical data from 272 MS patients treated with rituximab.
- Evaluation of relapses, disability progression, and side effects.
- Assessment of magnetic resonance imaging (MRI) findings, laboratory markers (including 25-hydroxy-vitamin D), and self-reported health status.
Main Results:
- A low rate of relapses (seven) and minimal new inflammatory lesions on MRI (1.3% T2 lesions, 0.25% contrast-enhancing) were observed during a mean follow-up of 43 months.
- Lower 25-hydroxy-vitamin D levels were associated with new T2 lesions on MRI (62 vs. 81 nmol/l).
- Elevated 25-hydroxy-vitamin D levels correlated with improved self-perceived health and lower C-reactive protein, but not with increased side effects.
Conclusions:
- Rituximab treatment in this MS population, with increasing vitamin D use, demonstrated exceptionally low inflammatory activity.
- Higher 25-hydroxy-vitamin D levels were associated with favorable outcomes, including better self-perceived health and reduced inflammation.
- These findings suggest a potential beneficial role for vitamin D in managing MS patients treated with rituximab.
Related Concept Videos
Vitamins
Conservation of Small Populations
What is Population Genetics?
Population Growth
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
What are Populations and Communities?

